Infection prevention and control will always be a concern for hospitals and health care facilities. Recent market analyses prove that point with predictions of continued growth coming from several organizations.
MarketsandMarkets is among those groups predicting continued growth in the global infection control market.
“The global infection control market is expected to reach $21.06 billion by 2022 from $15.35 billion in 2017, at a compound annual growth rate (CAGR) of 6.5 percent,” according to MarketsandMarkets. “Factors driving market growth include the increasing incidence of HAIs, rising number of surgical procedures owing to the rapidly growing geriatric population and increasing incidence of chronic disorders across the globe. In addition, the emerging market in China, India, Russia, and countries in Latin America; increasing use of e-beam sterilization; and rising importance of single-use medical nonwovens and medical devices are further increasing the demand for disinfection and sterilization products and services.”
“On the basis of products and services, the infection control market is segmented into disinfection products and sterilization products and services. In 2016, the disinfection products segment accounted for the largest share of the infection control market,” according to MarketsandMarkets. “The disinfection products segment will continue to dominate the infection control market, mainly due to the high prevalence of HAIs, rising number of surgeries, and increasing initiatives and regulatory actions taken by governments in various countries to fortify essential infection control standards.”
Hospitals and clinics are expected to register the highest CAGR during the forecast period.
“Based on end user, the global infection control market is segmented into hospitals and clinics, medical devices companies, food industry, life sciences industry, pharmaceutical companies and other end users,” according to MarketsandMarkets. “Hospitals and clinics are expected to register the highest CAGR during the forecast period. The growth in this end-user segment can be attributed to the factors such as the rising incidence of HAIs, growing volume of surgical procedures, increasing cost burden due to the rising geriatric population and incidence of chronic diseases, and increasing number of hospitals across the globe.”
The global infection control market is expected to reach $258.3 billion by 2025, according to a new report by Grand View Research Inc.
“The market is driven by rising concerns with respect to a significant upsurge in hospital acquired infections globally,” according to a Grand View Research news release. “This is believed to facilitate greater penetration of infection control products. An influx in development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall infection control market. The health care organizations are focused on implementing strategies for early recognition, reporting, isolation and surveillance of disease episodes of potential public health concern.”
In addition, an increasing number of intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years, the news release reports.
“For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection.
Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by health care personnel in wide array of health care settings such as ambulatory care, home care, hospitals and others. As a consequence of the aforementioned factors, it is presumed that there will be significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights,” according to Grand View Research.